Centiva Capital, LP Gossamer Bio, Inc. Transaction History
Centiva Capital, LP
- $5.76 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
132Shares Held
166MCall Options Held
2.15MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...